J2 Capital Management
MEDP icon

J2 Capital Management’s Medpace MEDP Stock Holding History

J2 Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04M Sell
1,662
-19
-1% -$11.1K 0.66% 24
2026
Q2 		$890K Buy
1,681
+595
+55% +$275K 0.6% 26
2026
Q1 		$521K Buy
+1,086
New +$556K 0.36% 77

Other funds holding MEDP

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Giverny Capital
Giverny Capital Montreal, Quebec, Canada $2.92B AUM 9.57% 1-Year Est. Return
Madison Asset Management
Madison Asset Management Madison, Wisconsin $8.05B AUM 13.78% 1-Year Est. Return

J2 Capital Management's MEDP Position: Q3 2026 in Review

J2 Capital Management reduced its Medpace (MEDP) stake by 1.1% in Q3 2026, selling an estimated $11.1K and leaving 1,662 shares worth $1.04M. The position accounts for 0.66% of the portfolio, ranked #24.

J2 Capital Management first reported a position in MEDP in Q1 2026 and has held it in 3 quarters since. 556 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • J2 Capital Management held 1,662 shares of Medpace worth $1.04M as of Q3 2026.
  • J2 Capital Management sold 19 Medpace shares in Q3 2026, an estimated $11.1K.
  • Medpace made up 0.66% of J2 Capital Management's portfolio in Q3 2026, its #24 holding.
  • J2 Capital Management first reported a position in Medpace in Q1 2026 and has held it in 3 quarters since.
  • 556 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on J2 Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.